Amicus Therapeutics, Inc. financial data

Symbol
FOLD on Nasdaq
Location
47 Hulfish Street, Princeton, NJ
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 307 % +9.66%
Quick Ratio 61 % +98.5%
Debt-to-equity 378 % -22.1%
Return On Equity -35.3 % +70.5%
Return On Assets -7.38 % +63.8%
Operating Margin 4.71 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 300M shares +1.6%
Common Stock, Shares, Outstanding 299M shares +1.86%
Entity Public Float 2.94B USD -17.3%
Common Stock, Value, Issued 2.94M USD +0.89%
Weighted Average Number of Shares Outstanding, Basic 304M shares +3.12%
Weighted Average Number of Shares Outstanding, Diluted 304M shares +3.12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 528M USD +32.3%
Operating Income (Loss) 24.9M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -28.8M USD +80.8%
Income Tax Expense (Benefit) 27.4M USD +1744%
Net Income (Loss) Attributable to Parent -56.1M USD +63%
Earnings Per Share, Basic -0.18 USD/shares +64.7%
Earnings Per Share, Diluted -0.18 USD/shares +64.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 214M USD -13.5%
Marketable Securities, Current 36.2M USD -7.68%
Accounts Receivable, after Allowance for Credit Loss, Current 101M USD +15.4%
Inventory, Net 119M USD +99%
Assets, Current 505M USD +4.49%
Property, Plant and Equipment, Net 29.4M USD -7.21%
Operating Lease, Right-of-Use Asset 22.3M USD -15.3%
Intangible Assets, Net (Excluding Goodwill) 17.2M USD -16.1%
Goodwill 198M USD 0%
Other Assets, Noncurrent 13.6M USD -26.5%
Assets 785M USD +0.92%
Accounts Payable, Current 12.9M USD -14.4%
Employee-related Liabilities, Current 32.5M USD -15.1%
Liabilities, Current 149M USD -11.3%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 45.1M USD -7.77%
Other Liabilities, Noncurrent 7.1M USD -46.6%
Liabilities 591M USD -4.33%
Retained Earnings (Accumulated Deficit) -2.74B USD -2.09%
Stockholders' Equity Attributable to Parent 194M USD +21.1%
Liabilities and Equity 785M USD +0.92%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.7M USD -64.3%
Net Cash Provided by (Used in) Financing Activities -13.3M USD -70.1%
Net Cash Provided by (Used in) Investing Activities 7.54M USD -79.2%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 299M shares +1.86%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -37.3M USD -414%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 217M USD -13.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 11.8M USD +3.87%
Deferred Tax Assets, Valuation Allowance 609M USD -6.18%
Deferred Tax Assets, Gross 617M USD -6.38%
Operating Lease, Liability 53.5M USD -6.41%
Payments to Acquire Property, Plant, and Equipment 1.81M USD -6.75%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -56.3M USD +58.1%
Lessee, Operating Lease, Liability, to be Paid 81M USD -9.86%
Property, Plant and Equipment, Gross 58.2M USD +1.86%
Operating Lease, Liability, Current 8.46M USD +1.57%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.36M USD +2.17%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.47M USD +2.49%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.13M USD -50.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.43M USD +2.31%
Deferred Tax Assets, Operating Loss Carryforwards 302M USD -5.9%
Unrecognized Tax Benefits 13.8M USD +182%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.14M USD -2.27%
Amortization of Intangible Assets 800K USD
Depreciation, Depletion and Amortization 8.55M USD +8.56%
Share-based Payment Arrangement, Expense 84.9M USD -1.36%
Interest Expense 50.7M USD +24.3%